Needham & Company Reiterates a 'Buy' on Vivus (VVUS); 4Q10 Review. Management Guiding for Qnexa NDA Resubmission by YE11
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' on Vivus (NASDAQ: VVUS), PT $15.
Needham analyst says, "Vivus provided a quarterly update ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "Vivus provided a quarterly update ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
